Skip to main content

Nadolol Side Effects

Medically reviewed by Last updated on Jan 18, 2023.

Applies to nadolol: oral tablets.

Side effects include:

Bradycardia (heart rate <60 bpm), peripheral vascular insufficiency (usually Raynaud’s type), dizziness, fatigue.

For Healthcare Professionals

Applies to nadolol: compounding powder, oral tablet.


The most common adverse reactions were bradycardia, cardiac failure, rhythm/conduction disturbances, symptoms of peripheral vascular insufficiency, hypotension, dizziness, and fatigue.[Ref]


Common (1% to 10%): Heart rate less than 60 beats per minute (bpm), heart rate less than 40 bpm, cardiac failure, rhythm/conduction disturbances, symptoms of peripheral vascular insufficiency usually of the Raynaud type, hypotension

Frequency not reported: First degree and third degree heart block, cold extremities[Ref]

Nervous system

Common (1% to 10%): Dizziness

Uncommon (0.1% to 1%): Paresthesias, sedation, headache, slurred speech, tinnitus

Frequency not reported: Lightheadedness[Ref]


Common (1% to 10%): Fatigue[Ref]


Uncommon (0.1% to 1%): Nausea, diarrhea, abdominal discomfort, constipation, vomiting, indigestion, bloating, flatulence, dry mouth[Ref]


Uncommon (0.1% to 1%): Rash, pruritus, dry skin, sweating, facial swelling

Frequency not reported: Reversible alopecia[Ref]


Uncommon (0.1% to 1%): Cough, nasal stuffiness, bronchospasm[Ref]


Uncommon (0.1% to 1%): Anorexia, weight gain

Frequency not reported: Hypoglycemia[Ref]


Uncommon (0.1% to 1%): Dry eyes, blurred vision[Ref]


Uncommon (0.1% to 1%): Change in behavior

Frequency not reported: Insomnia[Ref]


Uncommon (0.1% to 1%): Impotence or decreased libido[Ref]


1. "Product Information. Corgard (nadolol)." Bristol-Myers Squibb (2002):

2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.